RB Geller

434 total citations
11 papers, 358 citations indexed

About

RB Geller is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, RB Geller has authored 11 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 3 papers in Oncology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in RB Geller's work include Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). RB Geller is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). RB Geller collaborates with scholars based in United States. RB Geller's co-authors include Marianna Zahurak, John R. Wingard, HG Braine, AD Hess, GW Santos, WE Beschorner, Steven Piantadosi, Rein Saral, WH Burns and RF Ambinder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PubMed.

In The Last Decade

RB Geller

11 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RB Geller United States 9 301 101 83 69 58 11 358
R. Erttmann Germany 9 190 0.6× 58 0.6× 112 1.3× 59 0.9× 42 0.7× 16 344
T Iseki Japan 11 195 0.6× 67 0.7× 78 0.9× 50 0.7× 25 0.4× 20 320
A. Kashyap United States 6 324 1.1× 197 2.0× 100 1.2× 109 1.6× 18 0.3× 7 474
Gabriele Prange‐Krex Germany 6 270 0.9× 60 0.6× 52 0.6× 38 0.6× 51 0.9× 10 346
A. James Morton United States 3 276 0.9× 110 1.1× 55 0.7× 61 0.9× 18 0.3× 4 314
Diane S. Sempek United States 6 323 1.1× 66 0.7× 143 1.7× 57 0.8× 39 0.7× 7 397
Igor‐Wolfgang Blau Germany 7 262 0.9× 126 1.2× 67 0.8× 60 0.9× 31 0.5× 12 366
Jean W. Bjerke United States 4 395 1.3× 117 1.2× 79 1.0× 97 1.4× 18 0.3× 5 417
Brigitte Bär Netherlands 12 379 1.3× 157 1.6× 95 1.1× 63 0.9× 40 0.7× 16 438
T Chauncey United States 9 330 1.1× 98 1.0× 133 1.6× 45 0.7× 35 0.6× 12 362

Countries citing papers authored by RB Geller

Since Specialization
Citations

This map shows the geographic impact of RB Geller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RB Geller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RB Geller more than expected).

Fields of papers citing papers by RB Geller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RB Geller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RB Geller. The network helps show where RB Geller may publish in the future.

Co-authorship network of co-authors of RB Geller

This figure shows the co-authorship network connecting the top 25 collaborators of RB Geller. A scholar is included among the top collaborators of RB Geller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RB Geller. RB Geller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Devine, Steve, RB Geller, Liming Lin, et al.. (1997). The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.. PubMed. 3(1). 25–33. 31 indexed citations
2.
Devine, Steve, Nancy J. Newman, Gregory J. Joseph, et al.. (1996). Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.. PubMed. 18(3). 569–72. 17 indexed citations
3.
Geller, RB, et al.. (1995). Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia. Blood. 86(1). 60–65. 20 indexed citations
4.
Geller, RB & JE Karp. (1994). Adult acute leukemia: a need for continued translational research [letter]. Blood. 84(11). 3980–3981. 1 indexed citations
5.
Wagner, John E., Marianna Zahurak, Steven Piantadosi, et al.. (1992). Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.. Journal of Clinical Oncology. 10(5). 779–789. 36 indexed citations
6.
Geller, RB, et al.. (1989). A two-step timed sequential treatment for acute myelocytic leukemia. Blood. 74(5). 1499–1506. 10 indexed citations
7.
Geller, RB, GB Vogelsang, John R. Wingard, et al.. (1989). Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. Blood. 73(8). 2209–2218. 6 indexed citations
9.
Geller, RB, et al.. (1989). A two-step timed sequential treatment for acute myelocytic leukemia. Blood. 74(5). 1499–1506. 68 indexed citations
10.
Geller, RB, Rein Saral, Steven Piantadosi, et al.. (1989). Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. Blood. 73(8). 2209–2218. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026